Jarvick ... Lipitor ... Something did not seem right...

So a few weeks ago, we were over at Amy and Danny's for dinner, and somehow Lipitor came up (no, it had nothing to do with the dinner Amy was cooking!). Anyway, Amy said "Why is Jarvick a good person to promote a drug. I mean, that heart didn't work, right?"

Hmm.... Good point, I thought.

And now, today's news makes it all the more interesting...

WASHINGTON -- Pfizer Inc said on Monday it was voluntarily withdrawing advertising for its Lipitor cholesterol drug featuring Dr. Robert Jarvik, inventor of the Jarvik artificial heart, because its ads led to "misimpressions."

The ads involving Jarvik had come under scrutiny following an msnbc.com column written by NBC's Robert Bazell in March 2007. The column recounted Jarvik's past failures and pointed out that while he earned a medical degree, he didn't take an internship or practice medicine.

Actually, it isn't all that bad, really. I mean. why should we trust a medical scientist less than we would trust a doctor? Generally speaking, you can't assume a doctor knows anything about a particular topic until you see some evidence. So this whole flap is probably nothing more than a member of congress getting his rocks off.

Of course, that mechanical heart didn't really work, did it...

[Source: Newsmax]

Tags

More like this

You didn't think this one would go by without my commenting on it, did you? Even though Abel and Tara have already ably commented on it, I can't help but jump in because the article echoes one of the common threads of this blog since the very beginning. Besides, as I've said before, just because…
...instead of focusing on innovation. I've written about Pfizer and Lipitor a few times in the last year. Now, Pfizer has found a way to extend its patent on Lipitor, a very profitable drug used in the management of heart disease and high cholesterol. Lipitor's a great drug. It treats high…
Pfizer's Lipitor is the highest-grossing drug out there right now. This single molecule sells over $10B/year. As discussed in the allopurinol entry, this is another example of a small molecule enzyme inhibitor. The class to which it belongs, the statins, works on one key step of the steroid…
When the Wall Street Journal called attention to a claim that the Journal of the American Medical Association called a whistle-blower a "nobody" and a "nothing," a claim JAMA denied, I didn't know what to think. I was inclined to give JAMA the benefit of the doubt. Whatever dealings I've had (and…

"why should we trust a medical scientist less than we would trust a doctor?"

That may be a good point, but he didn't do research on statins. If it was an artificial heart ad... maybe.